Home > Altor Bioscience Salary

Altor Bioscience Salary

  • 76
  • 88
  • 55
Altor Bioscience average salary is $52,334, median salary is $51,000 with a salary range from $51,000 to $55,000.
Altor Bioscience salaries are collected from government agencies and companies. Each salary is associated with a real job position. Altor Bioscience salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
51,000
Average
52,334
Median
51,000
High
55,000
Total 3 Altor Bioscience Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Food Scientist (quality Assurance) 55,000-55,000 Piscataway, NJ, 08854 2017 Altor Bioscience Food Scientist (quality Assurance) Salaries (1)
Altor Bioscience Piscataway, NJ Salaries
Food Scientist, Quality Assurance Specialist 51,000-51,000 Piscataway, NJ, 08854 2014 Altor Bioscience Food Scientist, Quality Assurance Specialist Salaries (2)
Altor Bioscience Piscataway, NJ Salaries
Food Scientist, Quality Assurance Specialist 51,000-51,000 Piscataway, NJ, 08854 2013 Altor Bioscience Food Scientist, Quality Assurance Specialist Salaries (2)
Altor Bioscience Piscataway, NJ Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Altor Bioscience salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Altor Bioscience Jobs
See more Altor Bioscience Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Altor Bioscience... Information
  • Altor BioScience Corporation
  • Industry: BioTech/Drugs
  • City: Miramar, FL
  • Altor BioScience Corporation is a biopharmaceutical company developing a new class of therapeutic products for the treatment of cancer, viral infections and autoimmune diseases. Altor¡¯s drug discovery and therapeutic approaches are based on its patented soluble T-cell antigen receptor (STAR?) and single-chain major histocompatibility complex receptor (MHC) technologies. Altor is employing these novel technologies to improve the safety and efficacy of existing therapeutics. The clinical development strategy of evaluating these drugs in their approved indications will minimize risk and facilitate rapid progress in clinical trials. Altor will use its diverse product portfolio to support internal drug development programs and offer